EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
独家报道:Pasithea Treateutics宣布临床前研究结果表明,耐受疫苗对复发-缓解型多发性硬化症有效
EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis
独家报道:Pasithea Treateutics宣布临床前研究结果表明,耐受疫苗对复发-缓解型多发性硬化症有效